|

Thymoglobulin Clinical Trials

4 actively recruiting trials across 2 locations

▲ +1 trial since May 2026

Also known as: ATG

Pipeline

Phase 1: 1Phase 2: 3

Top Sponsors

  • University of Liege1
  • University of Birmingham1
  • St. Jude Children's Research Hospital1
  • Masonic Cancer Center, University of Minnesota1

Indications

  • Cancer4
  • Hodgkin Lymphoma2
  • Non-hodgkin Lymphoma2
  • Acute Myeloid Leukemia2
  • Hematologic Malignancy2

Other2 trials

Allogeneic Hematopoietic Cell Transplantation From HLA-matched Donor After Flu-Mel-PTCy Versus Flu-Mel-ATG Reduced-intensity Conditioning
Phase 2
Methods of T Cell Depletion Trial (MoTD)
Phase 2

Minneapolis, Minnesota1 trial

MT2021-08T Cell Receptor Alpha/Beta Depletion PBSC Transplantation for Heme Malignancies

University of Minnesota Masonic Cancer Center

Phase 2

Memphis, Tennessee1 trial

TCRαβ-depleted Progenitor Cell Graft With Early Memory T-cell DLI, Plus Selected Use of Blinatumomab, in naïve T-cell Depleted Haploidentical Donor Hematopoietic Cell Transplantation for Hematologic Malignancies

St. Jude Children's Research Hospital

Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.